Medicare Part B Inflation Rebate List Doubles For Third Quarter, Adds Several Amgen Drugs
Executive Summary
Amgen's Prolia appears to be the biggest drug on the list of products incurring price inflation penalties in Part B; many of the others have relatively low sales to Medicare.